Pharma & Bio
KOSDAQ
Samick Pharm Hits Daily Limit-Up on Hair Loss Theme; Kolon TissueGene and Lemon Healthcare Plunge [K-Bio Pulse]
South Korean pharmaceutical and biotech stocks posted mixed results on Wednesday. Samick Pharm surged to the daily limit as investors focused on its long-acting injectable platform technology, while O…
KOSDAQ
Hair Loss-Themed SAMIK PHARM. Co., LTD. Rises… Kolon TissueGene, Inc. and LEMON COMPANY LIMITED Down Over 20% [Bio Market Watch]
On the 16th, the domestic pharmaceutical and biotech sector saw mixed performance across individual stocks. #SAMIK PHARM. Co., LTD. hit the daily price limit, driven by its long-acting injectable plat…
Disclosure Plus
Pfizer Places Additional Order for Research Services on D&D Pharmatech Inc.’s Weight-Loss Drug… What Does This Mean?
D&D Pharmatech Inc.(347850)has secured an additional order from U.S.-based Pfizer related to the development of an oral obesity treatment formulation. Although the increase in the contract value amoun…
Lifestyle
[Blue Ocean Veterinary Medical Devices] ① Jeong Byeong-gon, President of the Korea Veterinary Medicines Association: “Focus on ‘Animal-Specific’ Products Derived from Human Medicines”
As medical technology advances, the treatment of human diseases is rapidly evolving into the era of “personalized medicine” and “precision medicine.” This shift is now spreading to the field of veteri…
Technology
Bin Jun-gil, CEO of NEUROPHET Inc.: "We Seized the 'Stroke' Market While Competitors Focused on Mild Conditions... on the Verge of Doubling Revenue"
The brain is like the most sophisticated electronic circuit in the human body. Imbalances in minute electrical signals can lead to life-threatening and severe diseases such as stroke, dementia, and de…
Lifestyle
“Zero Deaths in Four Years—How Was That Possible?”… 10 Questions for the Clinical Trial Lead at BigenCell’s VT-EBV-N Program
“The role of VT-EBV-N is to ensure that treated patients do not have to return to the hospital and to help them achieve a near-complete recovery.”Jeon Young-woo, a professor in the Department of Hemat…
Technology
Ki Min-hyo, CEO of Medici Bio: “Targeting the Next-Generation Gene Therapy Market with a Domestically Developed LNP Platform”
Ki Min-hyo, CEO of Medici Bio. (Photo courtesy of Medici Bio)
“While antibody therapies have driven the growth of the pharmaceutical and biotech industries in the past, I believe gene therapies wi…
Technology
The Survival Strategy for ‘Biotech Penny Stocks’ Frozen Even in the Height of Summer
Graphic: ChatGPT
Low-priced pharmaceutical and biotech stocks are collectively taking steps to defend their share prices in the securities market. This is because, starting this month, so-called “…
Manufacturing
“From Lituo to Estefil and Belpien”… Humedix Co., Ltd. Aims for a Quantum Leap in Earnings Led by Its “Aesthetic Trio”
#Huons Global Co., Ltd. subsidiary Humedix Co., Ltd.(200670)is expanding its aesthetic business portfolio. Humedix Co., Ltd. has been diversifying its revenue streams by expanding its business portfol…
Technology
PharmaResearch, Equipped with U.S.-Based CG USA, Accelerates Expansion into the U.S. ... What Is the Strategy for Reaching 1 Trillion Won in Sales?
PharmaResearch(214450)is staking its future on expanding into North America—the world’s largest beauty market—despite concerns over stagnant growth in its domestic market. At the same time, attention …